Manpreet Kalkat
Manpreet Kalkat
Verified email at
Cited by
Cited by
MYC Deregulation in Primary Human Cancers
M Kalkat, J De Melo, KA Hickman, C Lourenco, C Redel, D Resetca, ...
Genes 8 (6), 151, 2017
BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors
D Dingar, M Kalkat, PK Chan, T Srikumar, SD Bailey, WB Tu, E Coyaud, ...
Journal of proteomics 118, 95-111, 2015
Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop
A Pandyra, PJ Mullen, M Kalkat, R Yu, JT Pong, Z Li, S Trudel, KS Lang, ...
Cancer research 74 (17), 4772-4782, 2014
MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis
M Kalkat, D Resetca, C Lourenco, PK Chan, Y Wei, YJ Shiah, N Vitkin, ...
Molecular cell 72 (5), 836-848. e7, 2018
Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death
AA Pandyra, PJ Mullen, CA Goard, E Ericson, P Sharma, M Kalkat, R Yu, ...
Oncotarget 6 (29), 26909, 2015
Placental autophagy regulation by the BOK-MCL1 rheostat
M Kalkat, J Garcia, J Ebrahimi, M Melland-Smith, T Todros, M Post, ...
Autophagy 9 (12), 2140-2153, 2013
MYC phosphorylation at novel regulatory regions suppresses transforming activity
AR Wasylishen, M Chan-Seng-Yue, C Bros, D Dingar, WB Tu, M Kalkat, ...
Cancer research 73 (21), 6504-6515, 2013
MYC activity is negatively regulated by a C-terminal lysine cluster
AR Wasylishen, M Kalkat, SS Kim, A Pandyra, PK Chan, S Oliveri, ...
Oncogene 33 (8), 1066-1072, 2014
Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth
LC Lustig, D Dingar, WB Tu, C Lourenco, M Kalkat, I Inamoto, R Ponzielli, ...
Oncogene 36 (49), 6830-6837, 2017
Identification of c-MYC SUMOylation by mass spectrometry
M Kalkat, PK Chan, AR Wasylishen, T Srikumar, SS Kim, R Ponzielli, ...
PloS one 9 (12), e115337, 2014
MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability
D Dingar, WB Tu, D Resetca, C Lourenco, A Tamachi, J De Melo, ...
Nature communications 9 (1), 1-13, 2018
Data in Brief
PK Chan, T Srikumar, D Dingar, M Kalkat, LZ Penn, B Raught
More than MAX: discovering the Myc interactome
M Kalkat, AR Wasylishen, SS Kim, L Penn
Cell Cycle 10 (3), 374-375, 2011
Modelling the MYC-driven normal-to-tumour switch in breast cancer
C Lourenco, M Kalkat, KE Houlahan, J De Melo, J Longo, SJ Done, ...
Disease Models & Mechanisms 12 (7), dmm038083, 2019
MYC-dependent transformation model of triple-negative breast cancer in vivo
C Lourenco, M Kalkat, D Dingar, J De Melo, R Yu, L Penn
Cancer Research 77 (13 Supplement), 2558-2558, 2017
Characterizing Novel Regulators of MYC-dependent Tumorigenesis
M Kalkat
Charactering the interactomes of the Myc family of oncogenes
D Resetca, D Dingar, M Kalkat, B Raught, LZ Penn
Cancer Research 76 (14 Supplement), 2010-2010, 2016
The myc post-translational landscape: How novel gain-of-function mutants are revealing new stability and functional regulatory systems
C Lourenco, A Wasylishen, M Chan-Seng-Yue, C Bros, D Dingar, W Tu, ...
Abstract A12: Identifying MYC post-translational modifications using a mass spectrometry-based approach
D Resetca, M Kalkat, C Lourenco, PK Chan, T Srikumar, B Raught, ...
Molecular Cancer Research 13 (10 Supplement), A12-A12, 2015
Abstract A08: Identification of c-MYC SUMOylation by mass spectrometry
M Kalkat, PK Chan, AR Wasylishen, T Srikumar, SS Kim, R Ponzielli, ...
Molecular Cancer Research 13 (10 Supplement), A08-A08, 2015
The system can't perform the operation now. Try again later.
Articles 1–20